๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers

โœ Scribed by G. Melnik; W. H. Schwesinger; R. Teng; L. C. Dogolo; J. Vincent


Publisher
Springer
Year
1998
Tongue
English
Weight
364 KB
Volume
17
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Single-dose bioavailability of oral and
โœ P. Sandouk; M. Bouvier d'Yvoire; P. Chretien; J. P. Tillement; J. M. Scherrmann ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 289 KB ๐Ÿ‘ 2 views

A single dose of 8 mg of thiocolchicoside was administered to 12 healthy volunteers according to a Latin square design, either as tablets (reference), oral solution, or intramuscular injection. Serum thiocolchicoside concentrations showed an absorption phase followed by a biexponential decay with a

Single- and multiple-dose pharmacokineti
โœ Dan C. Dimmitt; Youn Sung Choo; Lorene A. Martin; Thangam Arumugham; William F. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 132 KB ๐Ÿ‘ 2 views

The single-and multiple-dose pharmacokinetics and dose-proportionality of oral dolasetron and its active metabolites over the therapeutic dose range was investigated in 18 healthy men. In an open-label, randomized, complete three-way crossover design, each subject received three separate doses: 50,

Pharmacokinetics of reboxetine in health
โœ D. M. F. Edwards; C. Pellizzoni; H. P. Breuel; A. Berardi; M. G. Castelli; E. Fr ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 885 KB

## Abstract The pharmacokinetics of reboxetine, a new antidepressant agent, were found to be close to linear in a crossover study comparing administration of single 2, 3, 4 and 5 mg capsule doses in 15 healthy male volunteers, and in the same study the capsules were bioequivalent to the proposed th

Pharmacokinetics of the active metabolit
โœ D. Beermann; H. G. Schaefer; M. Wargenau; B. Heibel; Y. Sturm; J. Kuhlmann ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer ๐ŸŒ English โš– 557 KB

The pharmacokinetics of BAY w 8199, the active metabolite of the prodrug repirinast (BAY u 2372), has been investigated after oral administration of 150, 300 and 450 mg repirinast to twelve healthy male Caucasians. Plasma BAY w 8199 concentrations were very variable between subjects. The mean peak l